ResearcherComplejo Hospitalario Universitario de SantiagoActive in the last 2 years
Elena Brozos-Vázquez
Matched on ORCID iD 0000-0003-4958-4142; OpenAlex author ID A5043726120. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 4
- Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHEIA-SEOM cohort. Co-author DOI 10.1007/s12094-026-04554-8↗
- Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. Co-author DOI 10.1016/j.pan.2026.08.008↗
- Unveilling the potential of liquid biopsy in pancreatic cancer for molecular diagnosis and treatment guidance. First author DOI 10.1016/j.critrevonc.2025.104807↗
- Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection. Co-author DOI 10.1016/j.ctrv.2024.102719↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maria Victoria García‐Ortiz · 2 shared papers, 2024–2025 · strength 0.50
- Marta Toledano‐Fonseca · 2 shared papers, 2024–2025 · strength 0.50
- Rafael López‐López · 2 shared papers, 2024–2025 · strength 0.50
- Antonio Rodríguez‐Ariza · 2 shared papers, 2024–2025 · strength 0.50
- Enrique Aranda Aguilar · 2 shared papers, 2024–2025 · strength 0.50
- Ángela Lamarca Lete · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Alberto Carmona‐Bayonas · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Vilma Pacheco-Barcía · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Javier Gallego-Plazas · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Carmen Guillén‐Ponce · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Ismael Ghanem · 1 shared paper, 2026 · strength 0.23
- Andrés Jesús Muñoz Martín · 1 shared paper, 2026 · strength 0.22
- Luis Cabezón‐Gutiérrez · 1 shared paper, 2026 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.